Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-26-000033

Chief Financial Officer acquired 37,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Davis Blaine · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +37,000 131,811 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +109,000 109,000 D
Loading xslF345X05/wk-form4_1767734322.xml…